| Ref | Description | Response | 
| 181//22FOI | Staff Spend 21/22 | 181 22 FOI - Final Response.doc | 
| 182/22/FOI | Temporary Staff Management | 182 22 FOI - Final Response.doc | 
| 183/22/FOI | Request on Nivolumab | 183 22 FOI- Final Response.doc | 
| 184/22/FOI | Spend on Interpreters | 184 22 FOI- Final Response.doc | 
| 185/22/FOI | Payments for Residential Mother and Baby Units | 185 22 FOI - Final Response.doc | 
| 186/22/FOI | Budget Report 2022 | 186 22 FOI - Final Response.doc | 
| 187/22/FOI | Infant Skincare Advice | 187 22 FOI- Final Response.doc | 
| 188/22/FOI | Policy Regarding Serious Incidents | 188 22 FOI- Final Response.doc | 
| 189/22/FOI | Confirmed Cases of Necrotising Fasciitis within Wrexham Maelor Hospital | 189 22 FOI- Final Response.doc | 
| 190/22/FOI | Waiting List Cancellations | |
| 191/22/FOI | Waiting List Cancellations | |
| 192/22/FOI | Patients Treated by Dermatology With Phototherapy (UVB or PUVA) | 192 22 FOI- Final Response.doc | 
| 193/22/FOI | Autistic Adults in Mental Health Facilities | 193 22 FOI- Final Response.doc | 
| 194/22/FOI | Details Around the Employment at Gardden Road | 194 22 FOI - Final Response.doc | 
| 195/22/FOI | Decision by Wrexham South Cluster to Employ Staff | |
| 196/22/FOI | Decision by Wrexham South Cluster to Employ Staff | 196 22 FOI - Final Response.doc | 
| 197/22/FOI | Aagency and Locum Spend | |
| 198/22/FOI | Lycra / Compression Suits for Children with Conditions Such as Cerebral Palsy | 198 22 FOI- Final Response.doc | 
| 199/22/FOI | Staffing Gaps and Overtime Payments | |
| 200/22/FOI | Number of Nurses and Midwives the Trust has Referred to Nursing and Midwifery Council (NMC) | 200 22 FOI - Final Response.doc | 
| 201/22/FOI | Restrictive Practice Within Mental Health Inpatient Settings | 201 22 FOI - Final Response.doc | 
| 202/22/FOI | ICT Expenditure | 202 22 FOI- Final Response.doc | 
| 203/22/FOI | Dental Practices in BCUHB Offering NHS Treatment | 203 22 FOI- Final Response.doc | 
| 204/22/FOI | Inpatient Meals with Eggs | |
| 205/22/FOI | Staff in Dermatology Department | 205 22 FOI - Final Response.doc | 
| 206/22/FOI | Electro-Convulsive Therapy (ECT) Patient Information Leaflets | 206 22 FOI- Final Response.doc | 
| 207/22/FOI | Distance Selling Pharmacies | 207 22 FOI- Final Response.doc | 
| 208/22/FOI | Contact Centre, CRM and AI & Automation | 208 22 FOI - Final Response.doc | 
| 209/22/FOI | Request on the Treatment of Haemophilia A | 209 22 FOI - Final Response.doc | 
| 210/22/FOI | Post-Operative Protocol | |
| 211/22/FOI | Benralizumab, Omalizumab, Reslizumab and Mepolizumab Request | 211 22 FOI- Final Response.doc | 
| 212/22/FOI | Dyspraxia/DCD Diagnostic Pathways in Children and Adults | 212 22 FOI - Final Response.doc | 
| 213/22/FOI | Best Interest Meeting | 213 22 FOI - Final Response.doc | 
| 214/22/FOI | Food Storage and Wastage Policy | 214 22 FOI- Final Response.doc | 
| 215/22/FOI | Off the Back of 165/22/FOI - number of reports on Patient Property Only | |
| 216/22/FOI | Complementary and Alternative Medicine (CAM) Questions | 216 22 FOI- Final Response.doc | 
| 217/22/FOI | Agency Nursing Fees | |
| 218/22/FOI | Primary Care Pathways for Lower Gastrointestinal Symptoms | 218 22 FOI - Final Response.doc | 
| 219/22/FOI | Current Endoscopy Maintenance Supplier and the Contract Expiry Date | 219 22 FOI- Final Response.doc | 
| 220/22/FOI | Autism, ADHD, Dyspraxia, Dyslexia and Tourette's Syndrome Waiting Times | |
| 221/22/FOI | Staff Retention Over Last 2 Years | |
| 222/22/FOI | Patients Treated (Revolade, Nplate, Doptelet, Tavlesse) | |
| 223/22/FOI | Community Services and Rehab Questions | |
| 224/22/FOI | Change in Health Board CEOs and Executive Directors - April 2017 to April 2022 | 224 22 FOI - Final Response.doc | 
| 225/22/FOI | Fistula Cannulas for Dialysis Questions | 225 22 FOI - Final Response.doc | 
| 226/22/FOI | Request on Clotting Disorders | 226 22 FOI - Final Response.doc | 
| 227/22/FOI | Denbigh Men's Shed Contract | 227 22 FOI- Final Response.doc | 
| 228/22/FOI | Denbigh Men's Shed Correspondence Pertaining to 1st June Suspension of Services | |
| 229/22/FOI | Myelofibrosis Treatment | 229 22 FOI -Final Response.doc | 
| 230/22/FOI | Children and Young People Admitted to an Adult Mental Health Ward | 230 22 FOI - Final Response.doc | 
| 231/22/FOI | Melanoma Patients and Treatment | 231 22 FOI- Final Response.doc | 
| 232/22/FOI | Telephony & Storage Questions | |
| 233/22/FOI | Admission Questions | |
| 234/22/FOI | Endoscopy Insourcing Providers | |
| 235/22/FOI | Agency Recruitment | |
| 236/22/FOI | Treatment for Lung Cancer | 236 22 FOI- Final Response.doc | 
| 237/22/FOI | Amount Of DNRS Over Last 5 Years at Glan Clwyd Hospital | 237 22 FOI - Final Response.doc | 
| 238/22/FOI | Mental Health Therapy and Counselling Waiting Lists | 238 22 FOI - Final Response.doc | 
| 239/22/FOI | Energy Costs Request | 239 22 FOI- Final Response.doc | 
| 240/22/FOI | Breast Cancer Treatment | |
| 241/22/FOI | Inbound and Outbound Post/ Mail | |
| 242/22/FOI | Delayed Transfers of Care | |
| 243/22/FOI | Pharmacological Choices in Hip/Knee Arthroplasty | |
| 244/22/FOI | Pregnancy Loss and Miscarriage |